Sumitomo Pharma Co., Ltd. (DNPUF)
OTCMKTS · Delayed Price · Currency is USD
8.97
+1.73 (23.90%)
At close: Aug 13, 2025
Sumitomo Pharma Market Cap
Sumitomo Pharma has a market cap or net worth of $4.12 billion as of August 29, 2025. Its market cap has increased by 265.23% in one year.
Market Cap
4.12B
Enterprise Value
6.09B
Revenue
2.88B
Ranking
n/a
PE Ratio
31.47
Stock Price
$8.97
Market Cap Chart
Since January 14, 1992, Sumitomo Pharma's market cap has increased from 1.62B to 4.12B, an increase of 153.89%. That is a compound annual growth rate of 2.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 4.12B | 189.73% |
| Dec 30, 2024 | 1.42B | 8.36% |
| Dec 29, 2023 | 1.31B | -56.36% |
| Dec 30, 2022 | 3.01B | -34.17% |
| Dec 30, 2021 | 4.57B | -21.94% |
| Dec 30, 2020 | 5.86B | -24.66% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 832.17M |
| Elite Pharmaceuticals | 705.48M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 655.63M |
| Northwest Biotherapeutics | 443.96M |
| CytoDyn | 393.58M |
| American Oncology Network | 358.34M |